The News
For anyone who is new to the story of Antibe Therapeutics (OTCQB: OTCQB:ATBPF), here is the SA news item that summarizes the announcement:
From a quick reading, the price action seems odd, given that the data appears positive.
Was the sell-off simply 'sell-on-the-news' volatility, which probably will recover eventually? (see below)
In other words, the sell-off could be a correction of the speculative run before the news, which is not uncommon for a clinical stage, micro-cap company like Antibe.
(Source: ATBPF All-time-chart up-to 2020-06-01)
As it is probably futile